Kidney study findings could boost the market for embolic protection devices
This article was originally published in Clinica
In what could boost sales of coronary embolic protection devices, an independent study has found that such devices may also be used to successfully remove harmful emboli in blood vessels supplying the kidney during routine angioplasty and stenting. In current procedures, emboli - abnormal particles such as blood clots that clog-up the vessel - can become dislodged and cause further harm elsewhere. If the devices can gain worldwide approval for this new indication, their use could be expanded to a further 100,000 procedures a year.